1 completed, 1 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow RFS Pharma, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects amdoxovir 300 mg bid, amdoxovir 500 mg bid - Human Immunodeficiency Virus Infection | Phase 2 | Withdrawn | RFS Pharma, LLC | 2013-04-01 | 2013-03-29 | |
| A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects. amdoxovir 300 mg bid, amdoxovir 500 mg bid, tenofovir DF 300 mg qd - Human Immunodeficiency Virus Infection | Phase 2 | Terminated | RFS Pharma, LLC | 2 | 2012-12-01 | 2014-11-05 |
| Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV zidovudine, amdoxovir, pharmacokinetic sampling - HIV Infections | Phase 1 / Phase 2 | Completed | RFS Pharma, LLC | 24 | 2007-02-01 | 2007-05-11 |
Acquired Immunodeficiency Syndrome (2) · HIV Infections (1)
amdoxovir (3) · BID protein, human (2) · Tenofovir (1) · Zidovudine (1)
Argentina (2)
Luz Pascual, MD MPH (2) · Carlos Zala, MD (1)